Biological age is an important factor in a patient's recovery after stroke and better stroke recovery is another benefit of healthy aging.
Receiving a Clot-Buster Drug may Reduce Stroke Disability
Time is brain in acute stroke after vascular collaterals fail, and faster treatment yields better outcomes.
Time is brain in acute stroke after vascular collaterals fail, and faster treatment yields better outcomes.
‘Biological age was estimated by analyzing a particular characteristic in DNA molecules that change over time (degree of methylation at 71 specific sites throughout the genome of the individual).’
Researchers analyzed 600 adults with ischemic stroke (clot-caused stroke) who were assessed in Hospital del Mar in Barcelona. Biological age was estimated by analyzing a particular characteristic in DNA molecules that change over time (degree of methylation at 71 specific sites throughout the genome of the individual). Researchers found DNA structure changes as a person gets older, so the extent of change can be used as an estimate of biological age. Other indicators that may also predict a patient's recovery are neurological status at admission, degree of changes in mobility after stroke, and promptness of the restoration of blood flow in the brain.
The findings suggest biological age is an important factor in a patient's recovery after stroke and better stroke recovery is another benefit of healthy aging, researchers said.
Nutritious Food may Increase Stroke Risk Factors
Food insecurity may lead to an increase in stroke risk factors and can complicate management of these health problems.
Food insecurity may lead to an increase in stroke risk factors and can complicate management of these health problems.
Use of Aspiration as Frontline Thrombectomy Therapy for Acute Ischemic Stroke
Penumbra's aspiration system provides an effective frontline thrombectomy approach for acute ischemic stroke.
Penumbra's aspiration system provides an effective frontline thrombectomy approach for acute ischemic stroke.
New Approach to Improve Stroke Treatment
A new way of combining tissue plasminogen activator (tPA) along with drugs that target a protein called plasma kallikrein may improve treatment for stroke.
A new way of combining tissue plasminogen activator (tPA) along with drugs that target a protein called plasma kallikrein may improve treatment for stroke.
